title: Organ system view of the hepatic innate immunity in HCV infection.
abstract: An orchestration of innate and adaptive immunity determines the infection outcome and whether the host achieves clearance or allows the pathogen to establish persistent infection. The robust activation of the innate immune response plays the most critical role in both limiting viral replication and halting the spread of the pathogen immediately after infection. The magnitude of innate immune activation is coupled with the efficient mounting of the adaptive immunity. Although immunity against HCV infection is known to be inadequate as most cases transitions to chronicity, approximately 25% of acute infection cases result in spontaneous clearance. The exact immune mechanisms that govern the infection outcome remain largely unknown; recent discoveries suggest that the innate immune system facilitates this event. Both infected hepatocytes and local innate immune cells trigger the front line defense program of the liver as well as the recruitment of diverse adaptive immune cells to the site of infection. Although hepatocyte is the target of HCV infection, nearly all cell types that exist in the liver are involved in the innate defense and contribute to the pathophysiology of hepatic inflammation. The main focus of this comprehensive review is to discuss the current knowledge on how each hepatic cell type contributes to the organ system level innate immunity against HCV infection as well as interplays with the viral evasion program. Furthermore, this review article also aims to synchronize the observations from both molecular biological studies and clinical studies with the ultimate goal of improving our understanding of HCV mediated hepatitis. J. Med. Virol. 88:2025-2037, 2016. © 2016 Wiley Periodicals, Inc.
authors.affiliation: Division of Gastrointestinal and Liver Diseases, Department of Medicine, USC Research Center for Liver Diseases, University of Southern California, Keck School of Medicine, Los Angeles, California.
authors.forename: Bo-Ram
authors.initials: BR
authors.lastname: Bang
authors.affiliation: Division of Gastrointestinal and Liver Diseases, Department of Medicine, USC Research Center for Liver Diseases, University of Southern California, Keck School of Medicine, Los Angeles, California.
authors.forename: Sandra
authors.initials: S
authors.lastname: Elmasry
authors.affiliation: Division of Gastrointestinal and Liver Diseases, Department of Medicine, USC Research Center for Liver Diseases, University of Southern California, Keck School of Medicine, Los Angeles, California. saitotak@usc.edu.|Department of Molecular Microbiology and Immunology, University of Southern California, Keck School of Medicine, Los Angeles, California. saitotak@usc.edu.|Department of Pathology, University of Southern California, Keck School of Medicine, Los Angeles, California. saitotak@usc.edu.
authors.forename: Takeshi
authors.initials: T
authors.lastname: Saito
mesh_terms: D056704:Adaptive Immunity; D003713:Dendritic Cells / Q000276:immunology / Q000821:virology; D016174:Hepacivirus / Q000276:immunology* / Q000502:physiology; D006526:Hepatitis C / Q000276:immunology*; D022781:Hepatocytes / Q000821:virology; D054884:Host-Pathogen Interactions; D006801:Humans; D057131:Immune Evasion; D007113:Immunity, Innate; D007372:Interferons / Q000276:immunology; D007728:Kupffer Cells / Q000821:virology; D008099:Liver / Q000276:immunology* / Q000821:virology; D015398:Signal Transduction; D014779:Virus Replication
chemical_list: D007372:Interferons
keywords: HCV; Kupffer cell; LSEC; dendritic cell; hepatocyte; innate immunity; viral hepatitis